Take Action Publications Press Room About Public Citizen Public Citizen Divisions Home
Advocates for justice, consumer access to the courts, and accountable government

JOIN US! |Take Action | Publications | About Congress Watch | Contact Us
Search

For Keyword(s)
advanced search

Email Signup

Sign up for our free activist updates.

Drug Industry:
Prices, Profits and R&D,
Campaign Contributions & Lobbying

  • Prescription Drug Prices

(11/7/02) Public Citizen's Post-Election Analysis: Handful of Senate Moderates Now Hold Key to Protecting Consumer Interests

(6/20/01) Washington Post: Prescription for Profit

(4/10/00) HHS Report Confirms Existence of Prescription Drug Price Discrimination

Full Text of the Health and Human Services Report to the President: Prescription Drug Coverage, Spending, Utilization and Prices

(1/26/00) Methods Used by European Countries To Obtain Reasonable Drug Prices for Consumers

Information on the Allen Bill: Prescription Drug Fairness for Seniors Act

Statement on International Drug Parity Act of 1999 (H.R. 1885/S. 1191)

  • Corporate Profits and Drug Industry R&D

(6/23/03) 2002 Drug Industry Profits: Hefty Pharmaceutical Company Margins Dwarf Other Industries

(6/26/02) Would Lower Prescription Drug Prices Curb Drug Company Research & Development?

(4/18/02) Pharmaceutical Industry Ranks as Most Profitable Industry, Again (Press Release)

(4/16/02) Pharmaceuticals Rank as Most Profitable Industry, Again

(12/4/01) Tufts Drug Study Sample Is Skewed; True Figure of R&D Costs Likely Is 75 Percent Lower

(12/4/01) Critique of the DiMasi/Tufts Methodology and Other Key Prescription Drug R&D Issues

(11/28/01) Rebuttals to PhRMA Responses to the Public Citizen Report, Rx R&D Myths: The Case Against The Drug Industry s R&D Scare Card

(7/23/01) Rx R&D Myths: The Case Against the Drug Industry's R&D "Scare Card"

(4/11/01) Drug Industry Most Profitable Again

(10/6/00) Consumer Group Releases Detailed Analysis of Prescription Drug Industry Profitability as Debate Over Prescription Drug Issue Heats Up in Election

(10/6/00) Analysis of Corporate Profits, 1999

(1/26/00) Merrill Lynch Finds the Prescription Drug Fairness for Seniors Act Would Cut Drug Company Revenues by Only 3.3%

  • Campaign Contributions and Lobbying

(6/23/2004) The Medicare Drug War: Drug Companies and HMOs Led an Army of Nearly 1,000 Lobbyists to Promote Misguided Legislation and Increase Profits

(6/23/2003) The Other Drug War 2003: Drug Companies Deploy an Army of 675 Lobbyists to Protect Profits

(11/7/02) Public Citizen's Post-Election Analysis: Handful of Senate Moderates Now Hold Key to Protecting Consumer Interests

(10/21/02) United Seniors Association: Hired Guns for PhRMA and Other Corporate Interests -- Updated October 17, 2002

(10/21/02) Seniors Group Continues to Do Bidding of Drug Industry, Sponsor "Issue Ads" to Help Industry Allies in Campaigns

(10/14/02) Who's Pulling the Strings in Washington? How Drug Industry Profits "Buy" Special Access to Congress

(8/12/02) Public Citizen Urges FEC to Investigate United Seniors Association (USA)

(8/9/02) Letter to the FEC Concerning United Seniors Association Issue Ads

(7/19/02) Brand-Name Drug Companies Versus Generics: Lobbying and Campaign Contributions

(7/19/02) Brand-Name Drug Industry Overwhelms Generic in Campaign Contributions and Lobbying Spending

(7/16/02) New Report Unmasks United Seniors Association as Hired Gun for Drug Industry

(7/12/02) United Seniors Association: Hired Guns for PhRMA and Other Corporate Interests

(6/26/02) The Other Drug War II: Drug Companies Use an Army of 623 Lobbyists to Keep Profits Up (Fact Sheet)

(6/13/02) Biggest Drug Companies Expand Lobbying Army in 2001

(6/12/02) The Other Drug War II: Drug Companies Use an Army of 623 Lobbyists to Keep Profits Up (Report)

(11/4/01) New York Times Coverage of Public Citizen's "The Other Drug War..." Report

(7/23/01) The Other Drug War: Big Pharma's 625 Washington Lobbyists

(11/1/00) Rx Industry Goes for KO: Drug Companies Spend Record Amount This Election Cycle

(9/21/00) Top Bush Health Adviser Stands To Gain Personally from Candidate's Medicare Plan

(7/6/00) Addicting Congress: Drug Companies' Campaign Cash & Lobbying Expenses

(7/20/00) Citizens for Better Medicare: The Truth Behind the Drug Industry's Deception of America's Seniors Designed to Mislead America s Seniors

(4/5/00) New Investigative Study Reveals How Unhealthy Alliance Between HMOs and Congressional Leaders Threatens Patients' Rights Bill

(1/26/00) PhRMA s Secret Playbook: "Insider" Documents Show Prescription Drug Industry Continues Campaign to Undermine Support for a Prescription Drug Benefit

(1/4/00) How the Prescription Drug Industry "Buys" Special Influence in Washington

(6/25/99) Pharmaceutical Industry's Propaganda Campaign Against the Prescription Drug Fairness for Seniors Act

(3/9/99) Deborah Steelman Collected Nearly $3 Million from Health Industry Interests with Major Stake in Medicare Reform

 

    » congress | reform | drug industry


Because Public Citizen does not accept funds from corporations, professional associations or government agencies, we can remain independent and follow the truth wherever it may lead. But that means we depend on the generosity of concerned citizens like you for the resources to fight on behalf of the public interest. If you would like to help us in our fight, click here.


Hot Issues
Publications
Join | Contact PC | Contribute | Site Map | Careers/Internships| Privacy Statement